InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,530.14
(
0.38%
)
US TECH 100
19,631.60
(
0.78%
)
Dow Jones
39,265.71
(
-0.17%
)
Brent Oil
86.37
(
-0.09%
)
Bitcoin
60,454.87
(
-2.53%
)
Post# of 252472
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 832
Posts 119974
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: JJM760 post# 113779

Tuesday, 02/01/2011 11:42:53 AM

Tuesday, February 01, 2011 11:42:53 AM

Post# of 252472

How is it that the Contrave denial and "bad" CRL is bad news for VVUS and good news for ARNA? Any thoughts?

I’ll take a shot. ARNA will (literally) need a miracle for Lorcaserin to be approved and, if the miracle should indeed occur, there is now one fewer competitor to share the market. VVUS requires something less than a miracle for Qnexa to be approved, so rational analysis still pertains.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up